Topics

Teva CEO unsure about 2020 growth

09:19 EDT 3 May 2019 | Globes

When Kåre Schultz assumed office in 2017, he earmarked 2020 as the year Teva would return to growth. Now he is not so certain.

Original Article: Teva CEO unsure about 2020 growth

NEXT ARTICLE

More From BioPortfolio on "Teva CEO unsure about 2020 growth"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...